Similarly, proteasome inhibition can significantly impair insulin signaling in 3T3-L1 adipocytes or further exacerbate insulin resistance in the myotubes derived from type 2 diabetic patients (Al-Khalili et al., 2014; Díaz-Ruiz et al., 2015). This evidence concerns the gene INS and type 2 diabetes mellitus.